Cloonan Michael 4
4 · Sionna Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Cloonan Michael
DirectorPresident & CEO
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2026-01-02+436,100→ 436,100 totalExercise: $39.21Exp: 2036-01-01→ Common Stock (436,100 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in forty-eight equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service on each such vesting date.